284 related articles for article (PubMed ID: 32139507)
1. The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.
Zhao Y; Wu TY; Zhao MF; Li CJ
J Biol Chem; 2020 Apr; 295(15):5152-5162. PubMed ID: 32139507
[TBL] [Abstract][Full Text] [Related]
2. Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditions.
Liu J; Jiang S; Zhao Y; Sun Q; Zhang J; Shen D; Wu J; Shen N; Fu X; Sun X; Yu D; Chen J; He J; Shi T; Ding Y; Fang L; Xue B; Li C
J Pathol; 2018 Nov; 246(3):277-288. PubMed ID: 29971772
[TBL] [Abstract][Full Text] [Related]
3. Does prenylation predict progression in NAFLD?
Ghorbani P; Smith TK; Fullerton MD
J Pathol; 2019 Mar; 247(3):283-286. PubMed ID: 30374976
[TBL] [Abstract][Full Text] [Related]
4. Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Wiemer AJ; Yu JS; Lamb KM; Hohl RJ; Wiemer DF
Bioorg Med Chem; 2008 Jan; 16(1):390-9. PubMed ID: 17905588
[TBL] [Abstract][Full Text] [Related]
5. Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target.
Muehlebach ME; Holstein SA
Clin Transl Med; 2023 Jan; 13(1):e1167. PubMed ID: 36650113
[TBL] [Abstract][Full Text] [Related]
6. Protein prenylation and human diseases: a balance of protein farnesylation and geranylgeranylation.
Xu N; Shen N; Wang X; Jiang S; Xue B; Li C
Sci China Life Sci; 2015 Apr; 58(4):328-35. PubMed ID: 25862656
[TBL] [Abstract][Full Text] [Related]
7. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
Wiemer AJ; Tong H; Swanson KM; Hohl RJ
Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation.
Agabiti SS; Liang Y; Wiemer AJ
Mol Membr Biol; 2016 Mar; 33(1-2):1-11. PubMed ID: 27537059
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers.
Waller DD; Park J; Tsantrizos YS
Crit Rev Biochem Mol Biol; 2019 Feb; 54(1):41-60. PubMed ID: 30773935
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate.
Wasko BM; Dudakovic A; Hohl RJ
J Pharmacol Exp Ther; 2011 May; 337(2):540-6. PubMed ID: 21335425
[TBL] [Abstract][Full Text] [Related]
11. Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation.
Danesi R; McLellan CA; Myers CE
Biochem Biophys Res Commun; 1995 Jan; 206(2):637-43. PubMed ID: 7826382
[TBL] [Abstract][Full Text] [Related]
12. Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors.
Berndt N; Sebti SM
Nat Protoc; 2011 Oct; 6(11):1775-91. PubMed ID: 22036881
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeranyl diphosphate synthase catalyzing the single condensation between isopentenyl diphosphate and farnesyl diphosphate.
Sagami H; Korenaga T; Ogura K
J Biochem; 1993 Jul; 114(1):118-21. PubMed ID: 8407863
[TBL] [Abstract][Full Text] [Related]
14. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth.
van de Donk NW; Lokhorst HM; Nijhuis EH; Kamphuis MM; Bloem AC
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):429-39. PubMed ID: 15701825
[TBL] [Abstract][Full Text] [Related]
15. Geranylgeranyl Diphosphate Synthase Modulates Fetal Lung Branching Morphogenesis Possibly through Controlling K-Ras Prenylation.
Jia WJ; Jiang S; Tang QL; Shen D; Xue B; Ning W; Li CJ
Am J Pathol; 2016 Jun; 186(6):1454-65. PubMed ID: 27106761
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors.
Reilly JE; Zhou X; Tong H; Kuder CH; Wiemer DF; Hohl RJ
Biochem Pharmacol; 2015 Jul; 96(2):83-92. PubMed ID: 25952057
[TBL] [Abstract][Full Text] [Related]
17. Alleviation of Hepatic Steatosis by 4-azidophlorizin via the Degradation of Geranylgeranyl Diphosphate Synthase by the Ubiquitin-Proteasome Pathway in Vivo and in Vitro.
Ye J; Qi Y; Chen J; Zhang S; Liu B; Zhao Y; Yuan X; Cheng Q; Yang Y; Zhang F; Gao H; Wang H; Wu J; Zhu F; Li C; Cao P; Xue B
Adv Biol (Weinh); 2023 Sep; 7(9):e2200150. PubMed ID: 36599632
[TBL] [Abstract][Full Text] [Related]
18. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
19. Geranylgeranyl diphosphate synthase: an emerging therapeutic target.
Wiemer AJ; Wiemer DF; Hohl RJ
Clin Pharmacol Ther; 2011 Dec; 90(6):804-12. PubMed ID: 22048229
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
Haney SL; Wills VS; Wiemer DF; Holstein SA
Molecules; 2017 May; 22(6):. PubMed ID: 28555000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]